Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00238264 · ClinicalTrials.gov registry record · Phase 2
Radiation Therapy in Treating Young Patients With Gliomas
A Phase 2 study, sponsored by Children's Oncology Group.
- Completed
- Registry status
- Phase 2
- Development phase
- 92
- Enrollment target
NCT00238264 is a Phase 2 study that has completed, run by Children's Oncology Group. The registered enrollment target is 92 participants.
The verdict
NCT00238264, a Phase 2 study, has completed, sponsored by Children's Oncology Group.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 92 participants
- Enrollment target
Study Summary
RATIONALE: Specialized radiation therapy that delivers radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue. PURPOSE: This phase II trial is studying how well radiation therapy works in treating young patients with gliomas.
Interventions
- RADIATION radiation therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 92 participants |
| Start Date | 2006-11 |
| Est. Completion | 2018-12-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00238264
The ClinicalTrials.gov registry entry for NCT00238264 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 92 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Oncology Group, which has 342 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which radiation therapy is the first listed.
NCT00238264 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00238264 about?
NCT00238264 is a clinical study titled "Radiation Therapy in Treating Young Patients With Gliomas". RATIONALE: Specialized radiation therapy that delivers radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue. PURPOSE: This phase II trial is studying how well radiation therapy works in treating young patients with gliomas.
What is the current status of trial NCT00238264?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 92 participants. The study started on 2006-11. Estimated completion is 2018-12-31.
What interventions are being tested in trial NCT00238264?
The interventions under investigation include: radiation therapy (RADIATION).
Who is sponsoring clinical trial NCT00238264?
This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.